Busy crowd of hundreds of people

Call for applications: Director, McGill Centre for Viral Diseases

Home

 

COVID-19  Faculty Updates

 

Welcome to the McGill Centre for Viral Diseases

Providing solutions to viral diseases that threaten public health by advancing research, education, and patient care through interdisciplinary efforts.

About UsL: Learn about the MCVD and our history

Our People:  Discover our membership of esteemed investigators

Research: Find out about the research themes pursued by the MCVD

Newsroom (March 31 2020)

Newsroom - tackling more COVID questions

Tackling more COVID questions

McGill medical experts returned for a follow up webcast to address an ever-growing range of questions related to the COVID-19 pandemic and its impact on us as individuals and as a community.

Dr. Marcel Behr, Co-Director, McGill Interdisciplinary Initiative in Infection and Immunity (Mi4) and Interim Director of McGill Infectious Diseases Division

Dr. Timothy Evans, Inaugural Director and Associate Dean of the School of Population and Global Health, Faculty of Medicine

Newsroom (Feb 5 2020)

Newsroom - fact and fiction with Dr. Evans and Dr. Chen

Coronavirus in context

Separating facts from fiction with McGill experts

In this special online discussion, two of McGill’s leading health experts discuss the risks, challenges and long-term outlook surrounding the novel coronavirus outbreak. With: Dr. Timothy Evans, Inaugural Director and Associate Dean of the School of Population and Global Health, Faculty of Medicine Dr. Chen Liang, Interim Director of the McGill AIDS Centre and member of the McGill Interdisciplinary Initiative in Infection and Immunity Scientific Advisory Committee. 

Featured Publication

Virus photo

A moonlighting microRNA enhances hepatitis C virus RNA accumulation

Selena M. Sagan’s Lab discovered that a human liver-specific microRNA, termed miR-122, enhances viral RNA accumulation of Hepatitis C virus (HCV). Together with Argonaute (Ago), miR-122 protects HCV RNA genome from cellular degradation and enhances translation from viral internal ribosome entry site. This work expands our knowledge of microRNA function and provides a novel example of how HCV takes advantage of the liver microenvironment to accumulate in cells. To find out more, check out: Amador-Cañizares Y et al. NAR 2018 and Chahal J et al. NAR 2019.

Acknowledging Dr. Wainberg

Photo of Dr. Wainberg in the lab

“When I look back on my career, I always feel that the most important contribution of my life was political and not scientific” -- Mark Wainberg, 1945-2017

In 1990 a group of McGill researchers, led by Dr. Mark Wainberg, came together to form the McGill AIDS Centre. They were united in their resolve to find solutions to the devastating HIV/AIDS epidemic. At the time, only 9 years after the first case of AIDS had been reported, 10 million people were already infected with HIV globally. There was no effective treatment available, morbidity and mortality from AIDS were rapidly increasing, and HIV-infected people were highly stigmatized.

Back to top